Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Tatva Chintan Pharma Chem Limited ( (IN:TATVA) ) is now available.
Tatva Chintan Pharma Chem Limited has scheduled a virtual one-on-one investor meeting with OysterRock Capital on 24 March 2026, as disclosed under SEBI’s listing obligations framework. The company emphasized that only publicly available information will be discussed during this interaction, with no confidential or unpublished price-sensitive information to be shared, underscoring its focus on regulatory compliance and transparent engagement with investors.
Details of the planned investor interaction will also be made available on the company’s website, reinforcing Tatva Chintan’s efforts to keep broader stakeholders informed of its investor relations activities. While the meeting schedule is subject to change, the disclosure signals continued outreach to institutional investors, which may support market understanding of the company’s business and governance practices.
More about Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited operates in the specialty chemicals and pharma intermediates space, supplying advanced chemical products to pharmaceutical and related industries. The company is listed on both BSE and the National Stock Exchange of India under the scrip code 543321 and symbol TATVA, reflecting its presence in India’s public capital markets.
Average Trading Volume: 4,123
Technical Sentiment Signal: Buy
Current Market Cap: 27.67B INR
See more data about TATVA stock on TipRanks’ Stock Analysis page.